Public health. U.S. panel favors wider use of preventive drug treatment.
作者信息
Couzin-Frankel Jennifer
出版信息
Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130.
PMID:20056859
Abstract
摘要
相似文献
1
Public health. U.S. panel favors wider use of preventive drug treatment.
Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130.
2
[The JUPITER study].
G Ital Cardiol (Rome). 2009 May;10(5):267-70.
3
Rosuvastatin in patients with elevated C-reactive protein.
N Engl J Med. 2009 Mar 5;360(10):1039-40; author reply 1041-2.
4
Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr. 2008 Nov-Dec;19(6):332-4, discussion 335.
5
Two more drugs for dyslipidemia.
Am J Cardiol. 2004 Mar 15;93(6):809-11. doi: 10.1016/j.amjcard.2004.01.022.
6
Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Science. 2008 Nov 14;322(5904):1039. doi: 10.1126/science.322.5904.1039.
7
Cardiovascular risk in uremic patients: darkness after AURORA.
Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652.
8
Was the FDA misled by JUPITER?
J Am Osteopath Assoc. 2010 Aug;110(8):424-5.
9
[JUPITER study, more reason to give statins as preventive measure - commentary].
Kardiol Pol. 2009 Mar;67(3):346-7.
10
Rosuvastatin in patients with elevated C-reactive protein.
N Engl J Med. 2009 Mar 5;360(10):1040; author reply 1041-2.
Zotero 插件